721 related articles for article (PubMed ID: 26317884)
21. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
22. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
[TBL] [Abstract][Full Text] [Related]
23. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
[TBL] [Abstract][Full Text] [Related]
24. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
25. A Microfluidic Spheroid Culture Device with a Concentration Gradient Generator for High-Throughput Screening of Drug Efficacy.
Lim W; Park S
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567363
[TBL] [Abstract][Full Text] [Related]
26. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
27. High-Throughput Screening of Anti-cancer Drugs Using a Microfluidic Spheroid Culture Device with a Concentration Gradient Generator.
Lee Y; Chen Z; Lim W; Cho H; Park S
Curr Protoc; 2022 Sep; 2(9):e529. PubMed ID: 36066205
[TBL] [Abstract][Full Text] [Related]
28. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures.
Sirenko O; Hesley J; Rusyn I; Cromwell EF
Assay Drug Dev Technol; 2014; 12(9-10):536-47. PubMed ID: 25506803
[TBL] [Abstract][Full Text] [Related]
29. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
30. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
31. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
[TBL] [Abstract][Full Text] [Related]
32. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional perfused tumour spheroid model for anti-cancer drug screening.
Wan X; Li Z; Ye H; Cui Z
Biotechnol Lett; 2016 Aug; 38(8):1389-95. PubMed ID: 27167883
[TBL] [Abstract][Full Text] [Related]
34. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
35. A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging.
Tseng H; Gage JA; Shen T; Haisler WL; Neeley SK; Shiao S; Chen J; Desai PK; Liao A; Hebel C; Raphael RM; Becker JL; Souza GR
Sci Rep; 2015 Sep; 5():13987. PubMed ID: 26365200
[TBL] [Abstract][Full Text] [Related]
36. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
37. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
38. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
39. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
40. An image-based assay to quantify changes in proliferation and viability upon drug treatment in 3D microenvironments.
Murali VS; Chang BJ; Fiolka R; Danuser G; Cobanoglu MC; Welf ES
BMC Cancer; 2019 May; 19(1):502. PubMed ID: 31138163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
